Literature DB >> 27574842

Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder.

Timothy E Wilens1,2,3, Joseph Biederman2,3, MaryKate Martelon2, Courtney Zulauf2, Jesse P Anderson2, Nicholas W Carrellas2, Amy Yule2, Janet Wozniak2, Ronna Fried2, Stephen V Faraone4.   

Abstract

OBJECTIVE: Bipolar disorder (BPD) is a highly morbid disorder increasingly recognized in adolescents. The aim of this study was to examine the relative risk for substance use disorders (SUDs; alcohol or drug abuse or dependence) and cigarette smoking in adolescents with BPD.
METHODS: We evaluated the relative risk for SUDs and cigarette smoking in a case-controlled, 5-year prospective follow-up of adolescents with (n = 105, mean ± SD baseline age = 13.6 ± 2.5 years) and without ("controls"; n = 98, baseline age = 13.7 ± 2.1 years) BPD. Seventy-three percent of subjects were retained at follow-up (BPD: n = 68; controls: n = 81; 73% reascertainment). Our main outcomes were assessed by blinded structured interviews for DSM-IV criteria.
RESULTS: Maturing adolescents with BPD, compared to controls, were more likely to endorse higher rates of SUD (49% vs 26%; hazard ratio [HR] = 2.0; 95% confidence interval (CI), 1.1-3.6; P = .02) and cigarette smoking (49% vs 17%; HR = 2.9; 95% CI, 1.4-6.1; P = .004), as well as earlier onset of SUD (14.9 ± 2.6 [SD] years vs 16.5 ± 1.6 [SD] years; t = 2.6; P = .01). Subjects with conduct disorder (CD) were more likely to have SUD and nicotine dependence than subjects with BPD alone or controls (all P values < .05). When we added conduct disorder to the model with socioeconomic status and parental SUD, all associations lost significance (all P values > .05). Subjects with the persistence of a BPD diagnosis were also more likely to endorse cigarette smoking and SUD in comparison to those who lost a BPD diagnosis or controls at follow-up.
CONCLUSIONS: The results provide further evidence that adolescents with BPD, particularly those with comorbid CD, are significantly more likely to endorse cigarette smoking and SUDs when compared to their non-mood disordered peers. These findings indicate that youth with BPD should be carefully monitored for comorbid CD and the development of cigarette smoking and SUDs. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27574842      PMCID: PMC6410713          DOI: 10.4088/JCP.14m09440

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  40 in total

1.  Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder.

Authors:  Ralph E Tarter; Levent Kirisci; Ada Mezzich; Jack R Cornelius; Kathleen Pajer; Michael Vanyukov; William Gardner; Timothy Blackson; Duncan Clark
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

2.  Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS).

Authors:  P J Ambrosini
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-01       Impact factor: 8.829

3.  Bipolar disorder during adolescence and young adulthood in a community sample.

Authors:  P M Lewinsohn; D N Klein; J R Seeley
Journal:  Bipolar Disord       Date:  2000-09       Impact factor: 6.744

4.  Early adolescent marijuana use: risks for the transition to young adulthood.

Authors:  J S Brook; R E Adams; E B Balka; E Johnson
Journal:  Psychol Med       Date:  2002-01       Impact factor: 7.723

Review 5.  Child psychopathology risk factors for drug abuse: overview.

Authors:  N Z Weinberg; M D Glantz
Journal:  J Clin Child Psychol       Date:  1999-09

6.  Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.

Authors:  S L McElroy; L L Altshuler; T Suppes; P E Keck; M A Frye; K D Denicoff; W A Nolen; R W Kupka; G S Leverich; J R Rochussen; A J Rush; R M Post
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

7.  Phenomenology and outcome of subjects with early- and adult-onset psychotic mania.

Authors:  G A Carlson; E J Bromet; S Sievers
Journal:  Am J Psychiatry       Date:  2000-02       Impact factor: 18.112

8.  Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults.

Authors:  Timothy E Wilens; Joseph Biederman; Janet Wozniak; Samantha Gunawardene; Jocelyn Wong; Michael Monuteaux
Journal:  Biol Psychiatry       Date:  2003-07-01       Impact factor: 13.382

9.  Psychiatric disorders in substance-abusing adolescent inpatients: a pilot study.

Authors:  R J Stowell; T W Estroff
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-11       Impact factor: 8.829

10.  Comorbidity in mania at first hospitalization.

Authors:  S M Strakowski; M Tohen; A L Stoll; G L Faedda; D C Goodwin
Journal:  Am J Psychiatry       Date:  1992-04       Impact factor: 18.112

View more
  9 in total

1.  Quantifying the Protective Effects of Stimulants on Functional Outcomes in Attention-Deficit/Hyperactivity Disorder: A Focus on Number Needed to Treat Statistic and Sex Effects.

Authors:  Joseph Biederman; Maura DiSalvo; Ronna Fried; K Yvonne Woodworth; Itai Biederman; Stephen V Faraone
Journal:  J Adolesc Health       Date:  2019-07-23       Impact factor: 5.012

2.  Comorbidity of bipolar I disorder and conduct disorder: a familial risk analysis.

Authors:  J Wozniak; T Wilens; M DiSalvo; A Farrell; R Wolenski; S V Faraone; J Biederman
Journal:  Acta Psychiatr Scand       Date:  2019-03-18       Impact factor: 6.392

Review 3.  The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders.

Authors:  Timothy E Wilens; Diana W Woodward; Je Deuk Ko; Amy F Berger; Colin Burke; Amy M Yule
Journal:  J Child Adolesc Psychopharmacol       Date:  2022-05-04       Impact factor: 3.031

4.  Further Evidence of the Diagnostic Utility of the Child Behavior Checklist for Identifying Pediatric Bipolar I Disorder.

Authors:  Amy Yule; Maura Fitzgerald; Timothy Wilens; Janet Wozniak; K Yvonne Woodworth; Alexa Pulli; Mai Uchida; Stephen V Faraone; Joseph Biederman
Journal:  Scand J Child Adolesc Psychiatr Psychol       Date:  2019-06-06

5.  The Effect of Traumatic Events on the Longitudinal Course and Outcomes of Youth with Bipolar Disorder.

Authors:  Maria Andreu Pascual; Jessica C Levenson; John Merranko; Mary Kay Gill; Heather Hower; Shirley Yen; Michael Strober; Tina R Goldstein; Benjamin I Goldstein; Neal D Ryan; Lauren M Weinstock; Martin B Keller; David Axelson; Boris Birmaher
Journal:  J Affect Disord       Date:  2020-05-22       Impact factor: 4.839

6.  High Correspondence Between Child Behavior Checklist Rule Breaking Behavior Scale with Conduct Disorder in Males and Females.

Authors:  Amy M Yule; Maura DiSalvo; Timothy E Wilens; Janet Wozniak; Stephen V Faraone; Rachael M Lyons; K Yvonne Woodworth; Joseph Biederman
Journal:  Child Psychiatry Hum Dev       Date:  2020-12

7.  Bipolar Disorder Associated with Another Autoimmune Disease-Pemphigus: A Population-based Study.

Authors:  Khalaf Kridin; Shira Zelber-Sagi; Doron Comaneshter; Arnon D Cohen
Journal:  Can J Psychiatry       Date:  2017-11-06       Impact factor: 4.356

8.  Does the course of manic symptoms in pediatric bipolar disorder impact the course of conduct disorder? Findings from four prospective datasets.

Authors:  Joseph Biederman; Maura Fitzgerald; K Yvonne Woodworth; Amy Yule; Elizabeth Noyes; Itai Biederman; Stephen V Faraone; Timothy Wilens; Janet Wozniak
Journal:  J Affect Disord       Date:  2018-05-24       Impact factor: 4.839

9.  Measuring Resilience in Women with Endometriosis.

Authors:  Daniel María Lubián-López; Davinia Moya-Bejarano; Carmen Aisha Butrón-Hinojo; Pilar Marín-Sánchez; Marta Blasco-Alonso; Jesús Salvador Jiménez-López; Emilia Villegas-Muñoz; Ernesto González-Mesa
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.